Blood irradiation is the process in which blood is exposed to low level of radiation which deactivates the T lymphocytes and inhibits the immune response for the prevention of rare graft-versus-host disease (GVHD). This therapy is also used for the treatment of various disorders such as autoimmune disorders, cancer, neuropathies and many more.
Hitachi Medical Systems and Best Theratronics – Notable Market Players in Blood Irradiation Market
The blood irradiation market is majorly comprised of top players involving Typenex Medical, LLC; Hitachi Medical Systems; Rad Source Technologies; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Actemium; and Best Theratronics Ltd among others.
The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the blood irradiation market:
| Year | News |
| June-2021 | Rad Source Technologies based in the USA, a supplier of commercial X-ray radiation products designed to replace self-shielded gamma irradiators, introduced its newly redesigned RS 3400 Blood Irradiator at MEDLAB Middle East 2021. |
| June-2019 | Gilardoni increases its presence at major international congresses in the blood transfusion sector with the Radgil2 medical x-ray irradiator. |
| November-2018 | JW Bioscience, a subsidiary of JW Pharmaceutical, launched Sangray, a new concept blood radiation device that does not use hazardous, radioactive materials. |
| September-2017 | Typenex Medical LLC launched Rad-Control – irradiation indication tag technology for blood banks and blood centers in the United States and Canada. |
